Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
Mata DA, Lee JK, Shanmugam V, Marcus CB, Schrock AB, Williams EA, Ritterhouse LL, Hickman RA, Janovitz T, Patel NR, Kroger BR, Ross JS, Mirza KM, Oxnard GR, Vergilio JA, Elvin JA, Benhamida JK, Decker B, Xu ML.
Mata DA, et al. Among authors: marcus cb.
Histopathology. 2024 Jun;84(7):1224-1237. doi: 10.1111/his.15168. Epub 2024 Feb 29.
Histopathology. 2024.
PMID: 38422618